Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.

Rudin, Charles M

Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar 2011 - 1075-82 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2010.32.5944 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Biomarkers, Tumor--blood
Carcinoma, Non-Small-Cell Lung--blood
Czech Republic
Disease-Free Survival
Double-Blind Method
Female
Glutamates--administration & dosage
Guanine--administration & dosage
Humans
Kaplan-Meier Estimate
Lung Neoplasms--blood
Male
Middle Aged
Pemetrexed
Proportional Hazards Models
Risk Assessment
Risk Factors
Sulfonamides--administration & dosage
Time Factors
Treatment Outcome
United States